img

#1

US IPO Issuance in 2022 - 2024 YTD3

img

#1

SPAC issuance in 2022 - 2024 YTD2

img

$23B+

in Gross Proceeds Raised3

img

300+

Transactions Completed3

Recent Transactions
February 1, 2020
img
img
Digital Ally
(Nasdaq: DGLY)

$2,900,000

Follow-On Offering
Sole Bookrunner

February 1, 2020
img
img
Zedge, Inc.
(NYSE: ZDGE)

$2,250,000

Registered Direct
Financial Advisor

January 1, 2020
img
Torchlight
(Nasdaq: TRCH)

$2,300,000

Follow-On Offering
Sole Bookrunner

January 1, 2020
img
NanoViricides
(AMEX: NNVC)

$8,625,000

Follow-On Offering
Sole Bookrunner

January 1, 2020
img
Avinger
(Nasdaq: AVGR)

$4,500,000

Follow-On Offering
Sole Bookrunner

December 1, 2019
img
Scynexis
(Nasdaq: SCYX)

$35,000,000

Follow-On Offering
Co-Manager

December 1, 2019
img
img
CEL-SCI Corporation
(NYSE: CVM)

$6,325,000

Follow-On Offering
Sole Bookrunner

December 1, 2019
img
Indonesia Energy Corp.
(NYSE: INDO)

$15,000,007


Sole Bookrunner

November 1, 2019
img
Arcimoto
(Nasdaq: FUV)

$9,000,000

Follow-On Offering
Joint Bookrunner

November 1, 2019
img
Document Security Systems
(NYSE: DSS)

$1,822,200

Private Placement
Placement Agent

October 1, 2019
img
Cocrystal Pharma
(Nasdaq: COCP)

$3,000,000

Follow-On Offering
Sole Bookrunner

October 1, 2019
img
Happiness Biotech
(Nasdaq: HAPP)

$11,000,000


Co-Manager

Insights
  • June 17, 2025

    D. Boral Capital acted as Exclusive Placement Agent to Brera Holdings PLC (Nasdaq: BREA) in connection with its $1.4 Million Registered Direct Offering

  • June 11, 2025

    D. Boral Capital acted as Sole Bookrunner to Aduro Clean Technologies Inc. (Nasdaq: ADUR) in connection with its $8.0 Million Follow-on Offering

  • June 10, 2025

    D. Boral Capital acted as Placement Agent in connection with a $4,850,000 Private Placement of SpaceX Series Interests

  • June 2, 2025

    D. Boral Capital Acted as Co-Placement Agent to Medicus Pharma Ltd. (Nasdaq: MDCX) in connection with its $7.0 Million Follow-On Offering

img

Together, let's build meaningful value.